Mountain View, Calif.
Went public 7/27/2000 at $12 per share
Filing Range: 3.6 mil. shares @ $11 to $13
Share Outstanding: 13.54 mil. shares
Underwriters: Salomon Smith Barney/Robertson Stephens
Company Counsel: Venture Law Group
Manager Counsel: Cravath, Swaine & Moore
Auditor: PricewaterhouseCoopers
The Company:
Develops radio frequency interstitial tissue ablation (RITA) devices that allows surgeons to treat tumors in cancerous tissues that may not be treated surgically. The company develops this cancer therapeutic device based on VidaMed’s technologies.
Venture Backers:
Patricof & Co. Ventures Inc.
Sequoia Capital
Delphi Ventures
Mohr, Davidow Ventures
Synergy Partners
BA Venture Partners
Digital Ventures
Financing Rounds:
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 06/17/1994 1 Early Stage 167.0
2 08/02/1994 1 Early Stage 1333.0
3 04/22/1996 3 Early Stage 282.0
4 12/20/1996 4 Later Stage 4212.0
5 01/29/1998 1 Expansion 2250.0
6 05/13/1998 8 Expansion 13515.0
7 08/10/1999 3 Expansion 12000.0
Financials:
(Data in $ millions)
Y/E
12/31/99
Total Revenues: $4.6
Net Income: -7.5